Newsletter

Idiopathic pulmonary fibrosis
Substantial growth is expected in the Idiopathic pulmonary fibrosis market size owing to multiple key drivers
IDIOPATHIC PULMONARY FIBROSIS

More Whitepapers / Newsletters

Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD), characterized by fibrosis and worsening lung function. It majorly affects the population older of...

Focal Segmental Glomerulosclerosis
Focal Segmental Glomeruloscler...

A rare glomerular kidney-scarring disease, Focal Segmental Glomerulosclerosis (FSGS) is a disease with prevalent cases of 196,333 in the 7MM as estimated by DelveInsight in 2017. However, poor knowled...

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies
ASCO Reveals: Increasing Optio...

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from cancer help to achieve complete remission that many other times, traditional chemotherapies fail to...

Warm Autoimmune Hemolytic Anemia
Warm Autoimmune Hemolytic Anem...

Autoimmune hemolytic anemia (AIHA) is a rare acquired autoimmune disease. It is caused by the dysfunction in the immune system in which the immune system attacks its red blood cells considering them f...

Fragile X Syndrome Newsletter
Fragile X Syndrome

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people, and is a result of mutation associated with the gene FMR1. D...